Synthesis of 6,6-Difluorocyclopropa[b]furo[2,3-c]pyrrole and 7-Fluoro­furo[3,2-c]pyridine Derivatives via 1,5-Electrocyclization of Carbene-Derived Azomethine Ylides

Abstract

Reaction of N-(5-R-furan-2-ylmethylidene)anilines with difluorocarbene, generated in CF₂Br₂/Pb*/Bu₄NBr/ultrasound system proceeds via 1,5-electrocyclization of intermediate azomethine ylides to give 6,6-difluorocyclopropa[b]furo[2,3-c]pyrrol-4(5H)-one or/and 4,4,6,6-tetrafluorocyclopropa[b]furo[2,3-c]pyrrole derivatives. Thermolysis of these compounds under solvent-free conditions gives rise to 2,5-disubstituted 7-fluoro-4,5-dihydrofuro[3,2-c]pyridine-4(5H)-ones in high yields.

Key words

ylides - carbenes - cylizations - fused heterocycles

References

• 1a Yue WS. Li JJ. Org. Lett.  2002,  2201 
• 1b Soldatenkov AT. Polyanskii KB. Soldatova SA. Chem. Heterocycl. Compd.  2002,  38:  368 
• 1c New JS. Christopher WL. Yevich JP. Butler R. Schlemmer RF. Van der Maelen CP. Cipollina JA. J. Med. Chem.  1989,  32:  1147 
• 1d Maffraund JP. Eloy F. Eur. J. Med. Chem. Chim. Ther.  1974,  483 
• 1e Podesta M. Aubert D. Furand JC. Eur. J. Med. Chem. Chim. Ther.  1974,  487 
• 1f Makikado T. inventors; Japanese Patent  7015985.  ; Chem. Abstr. 1970, 73, 77220
• 1g Makikado T. inventors; Japanese Patent  7033655.  ; Chem. Abstr. 1971, 74, 76400
• 1h Simpson WRJ. inventors; Ger. Offen  2350387.  ; Chem. Abstr. 1974, 81, 13555
• 1i inventors; Centre d’Etudes de l’Industrie Pharmaceutique. Ger. Offen  2404308.  ; Chem. Abstr. 1974, 81, 316131
• 2a Lhommet G. Sliwa H. Maitte P. Bull. Soc. Chim. Fr.  1972,  1442 
• 2b Bisagni E. Civier A. Marquet J.-P. J. Heterocycl. Chem.  1975,  12:  461 
• 2c Abramovitch RA. Deep A. Kishore D. Mpango GBW. Gazz. Chim. Ital.  1988,  118:  167 
• 2d Hörlein G. Kübel B. Studeneer A. Salbeck A. Liebigs Ann. Chem.  1979,  371 
• 2e Shiotani S. Morita H. Ishida T. Iu Y. J. Heterocycl. Chem.  1988,  25:  1205 
• 2f Moron J. Nguyen CH. Bisagni E. J. Chem. Soc., Perkin Trans. 1  1983,  225 
• 3a Eloy F. Deryckere A. Bull. Soc. Chim. Fr.  1971,  1442 
• 3b Eloy F. Deryckere A. J. Heterocycl. Chem.  1971,  8:  57 
• 3c Bouzart JD. Bisagni E. Bull. Soc. Chim. Fr.  1971,  1727 
• 3d Molina P. Fresneda PM. Hurtado F. Synthesis  1987,  45 
• 3e Krutosikova A. Dandarova M. Chilova J. Vegh D. Monatsh. Chem.  1992,  123:  807 
• 3f Korenova A. Krutosikova A. Kovac J. Celec S. Coll. Czech. Chem. Commun.  1987,  52:  192 
• 3g Bobosik V. Krutosikova A. Jordis U. Monatsh. Chem.  1995,  126:  747 
• 4a Khlebnikov AF. Novikov MS. Kostikov RR. Russ. Chem. J.  1999,  43:  70 
• 4b Novikov MS. Khlebnikov AF. Sidorina ES. Kostikov RR. J. Fluorine Chem.  1998,  90:  117 
• 4c Novikov MS. Khlebnikov AF. Krebs A. Kostikov RR. Eur. J. Org. Chem.  1998,  133 
• 4d Novikov MS. Khlebnikov AF. Sidorina ES. Kostikov RR. J. Chem. Soc., Perkin Trans. 1  2000,  231 
• 4e Novikov MS. Khlebnikov AF. Besedina OV. Kostikov RR. Tetrahedron Lett.  2001,  42:  533 
• 4f Voznyi IV. Novikov MS. Khlebnikov AF. Kopf J. Kostikov RR. J. Chem. Soc., Perkin Trans. 1  2002,  1628 
• 4g Novikov MS. Khlebnikov AF. Shevchenko MV. J. Fluorine Chem.  2003,  123:  177 
• 4h Khlebnikov AF. Novikov M. Amer AA. Tetrahedron Lett.  2002,  43:  8523 
• 5a Khlebnikov AF. Novikov MS. Kostikov RR. Adv. Heterocycl. Chem.  1996,  65:  93 
• 5b Novikov MS. Khlebnikov AF. Masalev AE. Kostikov RR. Tetrahedron Lett.  1997,  38:  4187 
• 5c Novikov MS. Khlebnikov AF. Sidorina ES. Masalev AE. Kopf J. Kostikov RR. Russ. J. Org. Chem.  2002,  38:  672 
• 5d Novikov MS. Khlebnikov AF. Kostikov RR. Russ. J. Org. Chem.  2002,  38:  1647 
• 6a McCarthy JR. Barney CL. O’Donnell MJ. Huffman JC. J. Chem. Soc., Chem. Commun.  1987,  469 
• 6b Khlebnikov AF. Novikov MS. Kostikov RR. Mendeleev Commun.  1997,  145 
• 7a Berg-Nielson K. Acta Chem. Scand., Ser. B  1977,  B31:  224 
• 7b Khlebnikov AF. Kostik EI. Kostikov RR. Chem. Heterocycl. Compd.  1991,  636 
• 7c Romashin YN. Liu MTH. Nijjar SS. Attanasi OA. Chem. Commun.   2000,  1147 
• 7d Bonneaua R. Romashin YN. Liu MTH. J. Photochem. Photobiol., A  1999,  126:  31 
• 7e Bonneau R. Romashin YN. Liu MTH. MacPherson SE. J. Chem. Soc., Chem. Commun.  1994,  509 
• 7f Liu MTH. Romashin YN. Bonneau R. Int. J. Chem. Kin.  1994,  26:  1179 
• 8a Romashin YN. Liu MTH. Bonneau R. Chem. Commun.  1999,  447 
• 8b Romashin YN. Liu MTH. Ma W. Moss RA. Tetrahedron Lett.  1999,  40:  7163 
• 9a Taylor EC. Turchi IJ. Chem. Rev.  1979,  79:  181 
• 9b Baldwin JE. Pudussery RG. Qureshi AK. Sklarz B. J. Am. Chem. Soc.  1968,  90:  5325 
• 10 Pinter A. Nyerges M. Viranyi A. Töke L. Tetrahedron Lett.  2003,  44:  2345 

11

General Procedure for Preparation of Compounds 3 and 4.
A flask containing active lead (1.2 g, 5.8 mmol) and CH₂Cl₂ (7 mL) was charged with Bu₄NBr (2.0 g, 6.0 mmol), imine 1a-f (2.7 mmol), and CBr₂F₂ (1.95 g, 9.3 mmol). The flask was tightly stopped, and the mixture was irradiated with ultrasound at 40 °C until the lead was completely consumed. Chromatography (hexane-EtOAc, 4:1) followed by recrystallization provided compounds 4 or/and 3.
5-(4-Bromophenyl)-4,4,6,6-tetrafluoro-2-(2-fluoro-phenyl)-4,5,5a,6-tetrahydro-3a H -cyclo-propa[ b ]fu-ro[2,3- c ]pyrrole ( 3d): mp 135-140 °C dec. (hexane-Et₂O). ¹H NMR (300 MHz, CDCl₃): δ = 3.88 (t, J _HF = 7.3 Hz, 1 H, 5a-H), 4.60 (dddd, J = 13.3, 6.4, 3.9, 2.6 Hz, 1 H, 3a-H), 5.93 (dd, J = 3.9, 2.6 Hz, 1 H, 3-H), 7.01-7.69 (m, 8 H, Ar-H). ¹³C NMR (75 MHz, CDCl₃): δ = 50.5 (t, J _CF = 15.5 Hz, 1a-C), 58.4 (t, J _CF = 32.1 Hz, 3a-C), 70.0 (m, 6a-C), 98.0 (d, J _CF = 14.4 Hz, 3-C), 109.7 (ddd, J _CF = 320, 302, 9.4 Hz, 6-C), 115.3, 115.6 (d, J _CF = 21.6 Hz), 116.6 (d, J _CF = 11.6 Hz), 118.4, 123.9 (d, J _CF = 3.9 Hz), 127.3 (d, J _CF = 1.7 Hz, C_Ar), 128.6 (ddd, J _CF = 260, 247, 5.5 Hz, 4-C), 130.9 (d, J _CF = 8.8 Hz), 131.8, 137.7 (d, J _CF = 5.0 Hz, C_Ar), 152.7 (2-C), 159.9 (d, J _CF = 254 Hz, C_Ar-F). Anal. Calcd for C₁₉H₁₁BrF₅NO: C, 51.38; H, 2.50; N 3.15. Found: C, 51.41; H, 2.75; N, 2.92. 6,6-Difluoro-5-phenyl-5a,6-dihydro-3a H -cyclo-propa[ b ]furo[2,3- c ]pyrrol-4 (5 H )-one ( 4a): mp 87-88 °C (hexane-Et₂O). IR (CHCl₃): 1725 (C=O) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 3.96 (dd, ³ J _HF = 8.2, 1.7 Hz, 1 H, 5a-H), 4.22 (dd, J = 4.5, 2.6 Hz, 1 H, 3a-H), 5.54 (dd, J = 4.5, 2.6 Hz, 1 H, 3-H), 6.62 (t, J = 2.6 Hz, 1 H, 2-H), 7.23-7.54 (m, 5 H, Ph-H). ¹³C NMR (75 MHz, CDCl₃): δ = 49.5 (dd, J _CF = 17.7, 15.5 Hz, 5a-C), 51.6 (d, J _CF = 1.7 Hz, 3a-C), 68.2 (dd, J _CF = 19.4, 11.1 Hz, 6a-C), 100.4 (d, J _CF = 1.1 Hz, 3-C), 108.5 (dd, J _CF = 319, 301 Hz, 6-C), 120.7, 125.7, 128.8, 137.3 (C_Ph), 147.5 (2-C), 170.8 (dd, J _CF = 3.9, 3.2 Hz, 4-C). Anal. Calcd for C₁₃H₉F₂NO₂: C, 62.65; H, 3.64; N, 5.62. Found: C, 62.64; H, 3.82, N, 5.73.

12

General Procedure for Preparation of Compounds 8. Compound 3 or 4 (0.52 mmol) is placed to a dry, 10 mL, one-necked round-bottomed flask and is heated at 160 °C for 10 min. Upon cooling to r.t. a brown solid forms; recrystallization from CH₂Cl₂-Et₂O mixture gives furo[3,2-c]pyridine 8 as a colorless solid.
7-Fluoro-5-phenylfuro[3,2- c ]pyridine-4 (5 H )-one ( 8a): mp 120-121 °C (CH₂Cl₂-Et₂O). IR (CHCl₃): 1630 (C=C), 1705 (C=O) cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.07 (dd, J _HH = 2.0 Hz, J _HF = 2.3 Hz, 1 H, 3-H), 7.28 (d, J _HF = 5.9 Hz, 1 H, 6-H), 7.39-7.52 (m, 5 H, Ar-H), 7.63 (d, 1 H, J _HH = 2.0 Hz, 2-H). ¹³C NMR (75 MHz, CDCl₃): δ = 108.2 (d, J _CF = 2.2 Hz, 3-C), 117.5 (d, J _CF = 3.3 Hz, 3a-C), 119.7 (d, J _CF = 32.6 Hz, 6-C), 126.5, 128.1, 129.0 (C_Ar), 137.8 (d, J _CF = 239 Hz, 7-C), 140.0 (C_Ar), 144.6 (2-C), 148.9 (d, J _CF = 15.5 Hz, 7a-C), 156.9 (4-C). Anal. Calcd for C₁₃H₈FNO₂: C, 68.12; H, 3.52; N 6.11. Found: C, 67.96; H, 3.55; N 6.08.